Carisma Therapeutics Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Carisma Therapeutics Inc. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $48.40 million as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2019-03-01
- 2018-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $48.40M.
- 2017-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $39.60M.
- 2016-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $45.10M.
- 2016-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $21.98M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2018-12-31 | $48.40M 10-K · filed 2019-03-01 |
| 2017-12-31 | $39.60M 10-K · filed 2019-03-01 |
| 2016-12-31 | $45.10M 10-K · filed 2018-04-02 |
| 2016-09-30 | $21.98M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $13.00K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 |
| 2015-12-31 | $115.00K 10-K · filed 2017-03-24 |
| 2015-09-30 | $33.00K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $96.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $1.92M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $3.22M 10-K · filed 2016-03-25 |
| 2013-12-31 | $297.00K 10-K · filed 2015-03-06 |